Search PubMed⌕ Search

Biomedical subjects

W R McCabe

Publications and source records attributed to W R McCabe.

At least 73 records · Page 4Linked to original sources

Nephrotoxicity associated with cephalothin administration.

Variable degrees of acute renal failure developed in three patients receiving therapy with cephalothin sodium. The course and findings were consistent with acute tubular necrosis of the oliguric and nonoliguric types. One patient had protracted oliguria, a second experienced transient oliguria, and one had normal urine output. All had urinary sediment changes consistent with tubular necrosis, and the two oliguric patients had elevated urine sodium concentrations. No other causes for renal failure could be detected, and all recovered after discontinuation of cephalothin therapy, although peritoneal dialysis was required in one patient. These observations indicate that cephalothin is capable of inducing renal damage in man.

Acute Kidney Injury↗

Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli.

Studies were carried out evaluating the protective activity of immunization with common enterobacterial antigen (CA) against challenge with heterologous gram-negative bacilli. Active immunization of mice with Escherichia coli 0:14 elicited titers of antibody to CA of 1:640 or greater but completely failed to enhance resistance to challenge by mouse virulent strains of Klebsiella pneumoniae or E. coli. Similarly, two lots, 324 and 422, of rabbit antisera to CA failed to afford passive protection to mice challenged with K. pneumoniae or E. coli. A third lot, 166, of rabbit antisera to CA did passively protect mice. The protective activity of antisera 166 was demonstrated to reflect its content of antibody to another cross-reactive antigen, Re determinant, of gram-negative bacilli which has previously been shown to protect against infections with heterologous bacilli rather than any protective effect of antibody to CA. These studies failed to demonstrate any protective activity of antibody to CA against challenge with heterologous CA containing gram-negative bacilli.

Adsorption↗

Common enterobacterial antigen. 3. Initial titers and antibody response in bacteremia caused by gram-negative bacilli.

Antibody titers to common enterobacterial antigen (CA) were determined in 141 controls and in acute serum specimens from 206 patients with bacteremia caused by gram-negative organisms. Levels of antibody to CA ranged from 1:160 to 1:2,560 in 95% of control subjects. These levels did not differ significantly from those in acute serum specimens from bacteremic patients with "nonfatal underlying diseases." Patients with more severe underlying diseases, "ultimately fatal underlying diseases," tended to have lower titers of antibody to CA. Human antibody to CA was predominantly of the 19S variety. A fourfold change in antibody titer to CA was observed in convalescent serum obtained after bacteremia in 32% of 108 patients studied. Correlation of titers of antibody to CA in acute serum specimens with the frequency of occurrence of shock or death failed to demonstrate any protective activity of antibody to CA. These complications occurred equally as often in patients with high titers of antibody to CA as in those with low titers.

Antibody Formation↗

Bacterial interference induced in embryonated eggs by staphylococci.

Studies of experimental infections in embryonated eggs demonstrated that prior allantoic infection with avirulent staphylococci afforded significant protection against subsequent challenge with virulent strains. All strains of coagulase-positive and coagulase-negative staphylococci tested that were relatively avirulent for embryonated eggs were capable of producing interference. The interference induced afforded protection not only against challenge with virulent staphylococci, but also against Diplococcus pneumoniae, Salmonella typhimurium, Escherichia coli, Proteus mirabilis, and one strain of influenza virus (A(2)J 305). Prior allantoic infection with avirulent staphylococci also protected against intravenous as well as allantoic infection with challenge strains.Interference required infection with viable bacteria. The onset of interference appeared within a few minutes after injection of the interfering strain, but was not maximal until 24 hours had elapsed between injection of the interfering and challenge strains. The protection afforded by the production of interference could not be overcome by increased inoculum size of the challenge strain and extended even to challenge with 10(9) bacteria. Studies of in vitro and in vivo growth of challenge strains in allantoic fluid demonstrated that some interfering strains inhibited growth of the challenge strains. Other strains produced interference without producing prolonged inhibition of the growth of challenge strains. Similarly, interference could not be attributed to attenuated virulence of the challenge organisms. All interfering strains studied produced enhanced bactericidal activity of whole blood from the affected embryos, but whether this affected leukocyte activity, opsonization, or other host defense mechanisms has yet to be determined.

Animals↗